Sunday, June 02, 2019 10:15:05 AM
The amount of volume this had on Friday 10x the outstanding, price should move early this upcoming week if not nearer the closing date on the exchange this month.
It was regardless a wild trading day Friday...
$SBOT
It was regardless a wild trading day Friday...
$SBOT
Recent EDSA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 09:02:20 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/03/2026 08:35:25 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2026 08:33:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:31:44 PM
- Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit • GlobeNewswire Inc. • 03/31/2026 08:20:00 PM
- Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment • GlobeNewswire Inc. • 03/26/2026 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 10:01:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:01:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:01:45 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 09:25:15 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/03/2026 12:03:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:05:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:01:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 02:21:03 PM
- Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study • GlobeNewswire Inc. • 02/24/2026 02:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 09:45:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:30:29 PM
- Edesa Biotech Reports Fiscal 1st Quarter 2026 Results • GlobeNewswire Inc. • 02/13/2026 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 10:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 02:00:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:45:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2025 09:40:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/12/2025 09:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:25:30 PM
